| Track 1: Gene Therapy |
| Track 1-1 |
Novel technologies for gene transfer |
| Track 1-2 |
Gene transfer to induce cellular reprogramming |
| Track 1-3 |
Molecular cloning in gene therapy |
| Track 1-4 |
Human gene therapy |
| Track 1-5 |
Gene therapy in plants |
| Track 1-6 |
Current research on gene therapy |
| Track 1-7 |
Genetic therapies for neurological disorders |
| Track 2: Vectors for Gene Therapy |
| Track 2-1 |
Viral vectors |
| Track 2-2 |
Non viral vectors |
| Track 2-3 |
Hybrid methods |
| Track 2-4 |
Immune response to gene therapy vectors |
| Track 2-5 |
Risk factors and biosafety issues of gene therapy vectors |
| Track 3: Cancer Genetics |
| Track 3-1 |
Oncogenes and alleles |
| Track 3-2 |
Tumor suppressor genes |
| Track 3-3 |
Targeted molecular therapies |
| Track 3-4 |
Therapeutic cancer vaccines |
| Track 4: Molecular Gene Therapy |
| Track 4-1 |
Bridging therapy |
| Track 4-2 |
Molecular biomarkers for gene therapy |
| Track 4-3 |
DNA vaccination |
| Track 4-4 |
Molecular imaging |
| Track 4-5 |
Uniting stem cells with gene therapy |
| Track 5: Developmental Genetics |
| Track 5-1 |
Immunogenetics |
| Track 5-2 |
Neurogenetics |
| Track 5-3 |
Human evolutionary genetics |
| Track 5-4 |
Population genetics |
| Track 5-5 |
Medical genetics and heredity counselling |
| Track 6: Genetic Disorders |
| Track 6-1 |
Single gene disorder |
| Track 6-2 |
Multifactorial and polygenic (complex) disorders |
| Track 6-3 |
Prognosis and treatment of genetic disorders |
| Track 6-4 |
Genetic syndrome associated with metabolisms |
| Track 6-5 |
Genomic instability |
| Track 6-6 |
Gene therapy for genetic syndromes |
| Track 7: Gene Therapy for Autoimmune Diseases & Epigenetics |
| Track 7-1 |
Hereditary multiple exostoses |
| Track 7-2 |
Adenomatous polyposis |
| Track 7-3 |
Genomic imprinting and related disorders |
| Track 7-4 |
Epigenetics in micro-organisms |
| Track 7-5 |
Induced pluripotent stem cells and potential therapies |
| Track 7-6 |
Transgenerational epigenetic observations |
| Track 7-7 |
Computational epigenetics |
| Track 8: Applied Molecular Biology |
| Track 8-1 |
Genetic variation and diversity |
| Track 8-2 |
Molecular evolution |
| Track 8-3 |
Genetic diseases caused by alterations of RNA sequence |
| Track 8-4 |
RNAi mechanisms and miRNAs |
| Track 9: Gene Therapy in the Retina |
| Track 9-1 |
Retinal degenerative disorders |
| Track 9-2 |
Vector based strategies for retinal gene therapies |
| Track 9-3 |
Nanoparticles in retinal gene therapy |
| Track 10: Clinical Genetics |
| Track 10-1 |
Pharmacogenetics |
| Track 10-2 |
Genetic amniocentesis |
| Track 10-3 |
Reproductive genetics |
| Track 10-4 |
Clinical applications, limitations, and future directions |
| Track 10-5 |
Genetic epidemiology |
| Track 11: Foreground Advancements of Gene Therapy and its Applications |
| Track 11-1 |
Gene therapy approaches for red blood cell disorders |
| Track 11-2 |
Pre-implantation genetic screening and diagnosis |
| Track 11-3 |
Self injurious and aggresive behaviour in genetic syndromes |
| Track 11-4 |
Adenovirus targeting for gene therapy |
| Track 11-5 |
Advanced techniques for gene therapy in cardiac disease |
| Track 11-6 |
Molecular therapy to renal diseases |
| Track 11-7 |
Recent advances in insulin gene therapy for diabetes |
| Track 12: Genetic Mapping and Linkage Analysis |
| Track 12-1 |
Cloning and expression systems |
| Track 12-2 |
Mobile genetic elements |
| Track 12-3 |
Cellular and organismal genetic engineering |
| Track 12-4 |
Pedigree/ Breeding analysis |
RSS
Facebook
LinkedIn
Twitter
Blog